2025-03-09 21:31:22 ET
Summary
- In recent years, Alphatec Holdings or "ATEC" has outperformed sales expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market.
- The company continues to benefit from M&A-related disruptions at key competitors, which has created opportunities for ATEC to grab additional market share.
- Following years of elevated cash usage, the company managed to generate free cash flow in the final quarter of 2024.
- As ATEC's business appears to have reached an inflection point, investors should consider buying the dip following last week's highly successful convertible notes offering.
- Reiterating "Buy" rating with a price target of $18.
Note:
I have discussed Alphatec Holdings, Inc. (NASDAQ: ATEC ) previously, so investors should view this article as an update to my earlier coverage of the company. ...
Read the full article on Seeking Alpha
For further details see:
Alphatec Holdings: Business Has Reached An Inflection Point - Buy The Dip
